Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
| ▸ | GBA1 | P04062 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25762052 | 1.00 | DNM1 (0.47) | DNM1GBA1THRBTSHRLPAR1 | |
| Hydrochloric Acid SCHEMBL28420787 | 0.93 | DNM1 (0.45) | DNM1GBA1LPAR1LPAR3LPAR2 | |
| SCHEMBL13898471 | 0.91 | ADRB2 (0.36) | DNM1TSHR | |
| SCHEMBL11614289 | 0.83 | DNM1 (0.44) | DNM1THRBLPAR1LPAR3LPAR2 | |
| SCHEMBL10878576 | 0.83 | DNM1 (0.44) | DNM1THRBLPAR1LPAR3LPAR2 | |
| SCHEMBL20443588 | 0.80 | DNM1 (0.45) | DNM1THRBTSHRLPAR1LPAR3 | |
| SCHEMBL29264833 | 0.80 | DNM1 (0.45) | DNM1HTT | |
| SCHEMBL8000872 | 0.79 | DNM1 (0.41) | DNM1LPAR1LPAR3LPAR2 | |
| SCHEMBL17793641 | 0.79 | DNM1 (0.37) | DNM1 | |
| SCHEMBL27590068 | 0.79 | DNM1 (0.41) | DNM1THRBLPAR1LPAR3LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11083793-B2 | Epidermal growth factor receptor (EGFR) targeted photosensitizers | HEALTH RESEARCH, INC. (US) | 2021-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11083793-B2 | Epidermal growth factor receptor (EGFR) targeted photosensitizers | EGFR, ERBB2, ERBB4 | DNM1 2044/4885GBA1 3211/4885THRB 501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.